about
New Natural Intergenotypic (2/5) Recombinant of Hepatitis C VirusHigh prevalence of anti-hepatitis E virus antibodies in blood donors from South West France.Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France.Hepatitis E virus antibodies in blood donors, France.Multicenter quality control of hepatitis C virus protease inhibitor resistance genotypingHepatitis E virus genotype 3 diversity, France.New NS5B polymerase inhibitors for hepatitis C.Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis CThe HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections.Full-length genome sequences of hepatitis C virus subtype 4f.Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV.Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers.Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France.Naturally occurring substitutions conferring resistance to hepatitis C virus polymerase inhibitors in treatment-naive patients infected with genotypes 1-5.Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.Genetic diversity of HCV genotype 2 strains in south western France.Hepatitis E virus and the kidney in solid-organ transplant patients.Hepatitis E virus-specific T-cell response after transplantation.Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France.Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient.
P50
Q27478380-A6B0CC32-0458-47FD-9845-073F5137EC19Q34008923-4AB57EEB-E78C-4793-BB16-1F2ABE51BFA4Q35817883-2A5FDFA5-A8AB-46C8-9B49-7C2B97310246Q35849075-E274B347-14A7-4B6B-A94D-6287365F4A35Q36826639-EBE900A9-1278-45B7-9AC2-3280DB7BBDA8Q37139914-E52C42D8-DD80-450F-9F93-2B166E1254D8Q37772518-635AEED3-FC7F-4FA6-B521-27B168A06F94Q39954275-D1EB35E7-99FF-47AF-A3D7-09EF42565F1CQ40485136-63BF3B84-9CD1-44A0-90EC-77949B3BC1CCQ42016304-6BEDE6A9-9FE8-4F71-8C65-FE6FBEBC2F5FQ42634988-A48E69C5-6E4B-45D8-90EA-D5944F3410D4Q42980241-DA3DAC69-DB56-4224-91F5-0536A4F18321Q42982341-843F495A-D813-4FB3-BD32-17ED1DF2E6C7Q42984149-EA1A1DB9-5A51-41E6-BC11-2A57FEE45F11Q42989489-A7853BA4-A745-4CF5-9D40-A4F0E6C07D84Q42990352-4DF1B8C7-0CFA-400A-855D-59A6F51C1AB5Q42992084-01A1D6A2-79AA-42DD-A0B0-98B40B005254Q42997679-93D777E8-59B7-4F6B-9085-358CDB476009Q43033457-DCD74A54-B0F2-4620-8F46-A51C82D749ABQ43034073-1599D46C-0C9E-4817-AA17-E11BE699AF87Q45359963-764438C9-9BFA-4FA2-AFF3-8F06FE9F8C20Q45360522-CF7F7BE2-ECE5-4A66-BF73-679308EF0638Q45373867-4E8CE539-923B-4B93-A0B8-6F961801AF59Q45514540-64CCDB29-3A3F-4CCA-AADF-8201A133CDE3
P50
name
Florence Legrand-Abravanel
@ast
Florence Legrand-Abravanel
@en
Florence Legrand-Abravanel
@es
Florence Legrand-Abravanel
@nl
type
label
Florence Legrand-Abravanel
@ast
Florence Legrand-Abravanel
@en
Florence Legrand-Abravanel
@es
Florence Legrand-Abravanel
@nl
prefLabel
Florence Legrand-Abravanel
@ast
Florence Legrand-Abravanel
@en
Florence Legrand-Abravanel
@es
Florence Legrand-Abravanel
@nl